Investigating the role of C9orf72 in autophagic and metabolic dysregulation in ALS/FTD

研究 C9orf72 在 ALS/FTD 自噬和代谢失调中的作用

基本信息

  • 批准号:
    10606605
  • 负责人:
  • 金额:
    $ 56.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-05-15 至 2025-04-30
  • 项目状态:
    未结题

项目摘要

Neurodegeneration is an increasing public health issue and remains an unsolved biomedical challenge. Genetic discoveries have provided news avenues for investigating the molecular mechanisms of several neurodegenerative diseases. Recently, a hexanucleotide repeat expansion in a noncoding region of the C9orf72 gene was linked to the neurodegenerative disease amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). ALS is characterized by loss of motor neurons, and the C9orf72 mutation represents the most common genetic cause of both familial and sporadic ALS. FTD is characterized by degeneration of the frontal and temporal lobes of the brain and is the second most common type of dementia for people older than 65; the C9orf72 mutation is also the most common genetic causes for FTD. The C9orf72 mutation is also found to contribute to Alzheimer’s disease and Huntington’s disease. Despite intense efforts and rapid advances, our understanding of the disease mechanisms and treatment strategies for C9orf72-linked ALS/FTD are still at the early stages. To help relieve the public health burden associated with these diseases, it is important to understand the mechanisms underlying the pathogenesis. We have recently discovered that C9orf72 plays an important role in the regulation of autophagy and related metabolic processes, suggesting that further studies of C9orf72 functions could shed light on the mechanism of ALS/FTD pathogenesis. The goal of the proposed project is to elucidate the mechanisms through which dysregulation of C9orf72 functions leads to molecular defects and neuronal toxicity. The specific aims are to identify the central mechanisms through which C9orf72 regulates autophagy and related metabolism, to delineate the pathways through which the pathogenesis is generated, and to identify potential intervention strategies. The proposed studies, which combine biochemical, molecular, and genetic approaches, are expected to provide insight into fundamental mechanisms of neurodegeneration in ALS/FTD that may ultimately leads to novel approaches for treating these devastating neurodegenerative diseases.
神经退行性变是一个日益严重的公共卫生问题, 生物医学挑战遗传学的发现为研究人类基因组提供了新的途径。 几种神经退行性疾病的分子机制最近,一种六核苷酸 在C9 orf 72基因的非编码区的重复扩增被链接到 神经退行性疾病肌萎缩侧索硬化症(ALS)和额颞叶痴呆 (FTD)。ALS的特征在于运动神经元的丧失,并且C9 orf 72突变代表了ALS的特征。 是家族性和散发性肌萎缩侧索硬化症最常见的遗传原因。FTD的特征在于 大脑额叶和颞叶的退化,是第二常见的 一种65岁以上的痴呆症; C9 orf 72突变也是最常见的 FTD的遗传原因。C9 orf 72突变也被发现有助于阿尔茨海默病 和亨廷顿舞蹈症。尽管付出了巨大的努力和快速的进步,我们对 C9 orf 72连锁ALS/FTD的疾病机制和治疗策略仍处于早期阶段, 阶段为了帮助减轻与这些疾病相关的公共卫生负担, 以了解发病机制。我们最近发现, C9 orf 72在自噬和相关代谢过程的调节中起重要作用, 这表明对C9 orf 72功能的进一步研究可以阐明 ALS/FTD发病机制。该项目的目标是阐明 C9 orf 72功能失调导致分子缺陷, 毒性具体的目的是确定C9 orf 72 调节自噬和相关的代谢,以描绘通过哪些途径, 发病机制的产生,并确定潜在的干预策略。拟议 结合了生物化学、分子生物学和遗传学方法的联合收割机研究, 深入了解ALS/FTD中神经变性的基本机制, 最终导致治疗这些破坏性神经退行性疾病的新方法。

项目成果

期刊论文数量(21)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Autophagy as a common pathway in amyotrophic lateral sclerosis.
  • DOI:
    10.1016/j.neulet.2018.04.006
  • 发表时间:
    2019-04-01
  • 期刊:
  • 影响因子:
    2.5
  • 作者:
    Nguyen DKH;Thombre R;Wang J
  • 通讯作者:
    Wang J
Cell-type specific differences in promoter activity of the ALS-linked C9orf72 mouse ortholog.
  • DOI:
    10.1038/s41598-017-05864-2
  • 发表时间:
    2017-07-18
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    Langseth AJ;Kim J;Ugolino JE;Shah Y;Hwang HY;Wang J;Bergles DE;Brown SP
  • 通讯作者:
    Brown SP
Heterochronic Phenotype Analysis of Hypodermal Seam Cells in Caenorhabditis elegans.
秀丽隐杆线虫皮下接缝细胞的异时表型分析。
  • DOI:
    10.21769/bioprotoc.3132
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    0.8
  • 作者:
    Ji,YonJu;Wang,Jiou
  • 通讯作者:
    Wang,Jiou
A Helicase Unwinds Hexanucleotide Repeat RNA G-Quadruplexes and Facilitates Repeat-Associated Non-AUG Translation.
  • DOI:
    10.1021/jacs.1c00131
  • 发表时间:
    2021-05-19
  • 期刊:
  • 影响因子:
    15
  • 作者:
    Liu H;Lu YN;Paul T;Periz G;Banco MT;Ferré-D'Amaré AR;Rothstein JD;Hayes LR;Myong S;Wang J
  • 通讯作者:
    Wang J
USP7 regulates ALS-associated proteotoxicity and quality control through the NEDD4L-SMAD pathway.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jiou Wang其他文献

Jiou Wang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jiou Wang', 18)}}的其他基金

Molecular Basis of Pathogenic Cascades in ALS/FTD Initiated from C9orf72 Hexanucleotide Repeat Expansion
C9orf72 六核苷酸重复扩增引发 ALS/FTD 致病级联的分子基础
  • 批准号:
    10512236
  • 财政年份:
    2022
  • 资助金额:
    $ 56.75万
  • 项目类别:
Molecular Basis of Pathogenic Cascades in ALS/FTD Initiated from C9orf72 Hexanucleotide Repeat Expansion
C9orf72 六核苷酸重复扩增引发 ALS/FTD 致病级联的分子基础
  • 批准号:
    10659232
  • 财政年份:
    2022
  • 资助金额:
    $ 56.75万
  • 项目类别:
Mechanisms of RNA and Protein Dysregulations in ALS/FTD Associated with FUS and Ubiquilin 2
与 FUS 和泛素 2 相关的 ALS/FTD 中 RNA 和蛋白质失调的机制
  • 批准号:
    10530653
  • 财政年份:
    2019
  • 资助金额:
    $ 56.75万
  • 项目类别:
Mechanisms of RNA and Protein Dysregulations in ALS/FTD Associated with FUS and Ubiquilin 2
与 FUS 和泛素 2 相关的 ALS/FTD 中 RNA 和蛋白质失调的机制
  • 批准号:
    10401555
  • 财政年份:
    2019
  • 资助金额:
    $ 56.75万
  • 项目类别:
Mechanisms of RNA and Protein Dysregulations in ALS/FTD Associated with FUS and Ubiquilin 2
与 FUS 和泛素 2 相关的 ALS/FTD 中 RNA 和蛋白质失调的机制
  • 批准号:
    10318610
  • 财政年份:
    2019
  • 资助金额:
    $ 56.75万
  • 项目类别:
Investigating the role of C9orf72 in autophagic and metabolic dysregulation in ALS/FTD
研究 C9orf72 在 ALS/FTD 自噬和代谢失调中的作用
  • 批准号:
    10400837
  • 财政年份:
    2015
  • 资助金额:
    $ 56.75万
  • 项目类别:
Investigating the role of C9orf72 in autophagic and metabolic dysregulation in ALS/FTD
研究 C9orf72 在 ALS/FTD 自噬和代谢失调中的作用
  • 批准号:
    10133157
  • 财政年份:
    2015
  • 资助金额:
    $ 56.75万
  • 项目类别:
Investigating disease Mechanisms in C9orf72-linked ALS/FTD
研究 C9orf72 相关 ALS/FTD 的疾病机制
  • 批准号:
    9066822
  • 财政年份:
    2015
  • 资助金额:
    $ 56.75万
  • 项目类别:
Investigating the role of C9orf72 in autophagic and metabolic dysregulation in ALS/FTD
研究 C9orf72 在 ALS/FTD 自噬和代谢失调中的作用
  • 批准号:
    9904831
  • 财政年份:
    2015
  • 资助金额:
    $ 56.75万
  • 项目类别:
Neurodegeneration and Proteotoxicity Dissected in C. elegans and Mammals
线虫和哺乳动物的神经变性和蛋白质毒性剖析
  • 批准号:
    9281039
  • 财政年份:
    2011
  • 资助金额:
    $ 56.75万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 56.75万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 56.75万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 56.75万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 56.75万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 56.75万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 56.75万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 56.75万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 56.75万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 56.75万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 56.75万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了